Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei.

We report the isolation and pharmacological characterization of conicasterol E isolated from the marine sponge Theonella swinhoei. Pharmacological characterization of this steroid in comparison to CDCA, a natural FXR ligand, and 6-ECDCA, a synthetic FXR agonist generated by an improved synthetic strategy, and rifaximin, a potent PXR agonist, demonstrated that conicasterol E is an FXR modulator endowed with PXR agonistic activity. Conicasterol E induces the expression of genes involved in bile acids detoxification without effect on the expression of small heterodimer partner (SHP), thus sparing the expression of genes involved in bile acids biosynthesis. The relative positioning in the ligand binding domain of FXR, explored through docking calculations, demonstrated a different spatial arrangement for conicasterol E and pointed to the presence of simultaneous and efficient interactions with the receptor. In summary, conicasterol E represents a FXR modulator and PXR agonist that might hold utility in treatment of liver disorders.

[1]  L. Adorini,et al.  Extending SAR of bile acids as FXR ligands: discovery of 23-N-(carbocinnamyloxy)-3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine. , 2011, Bioorganic & medicinal chemistry.

[2]  Roberto Pellicciari,et al.  Structural basis for bile acid binding and activation of the nuclear receptor FXR. , 2003, Molecular cell.

[3]  S. Fiorucci,et al.  Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. , 2010, Current medicinal chemistry.

[4]  R. Evans,et al.  Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. , 2003, Organic & biomolecular chemistry.

[5]  V. Sepe,et al.  Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei , 2009 .

[6]  U. Deuschle,et al.  Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists. , 2010, Bioorganic & medicinal chemistry letters.

[7]  T. Willson,et al.  6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. , 2002, Journal of medicinal chemistry.

[8]  E. Distrutti,et al.  Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells. , 2010, Biochemical pharmacology.

[9]  G. Bifulco,et al.  Theonellasterols and conicasterols from Theonella swinhoei. Novel marine natural ligands for human nuclear receptors. , 2011, Journal of medicinal chemistry.

[10]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[11]  F. Baldelli,et al.  Farnesoid X receptor agonists in biliary tract disease , 2009, Current opinion in gastroenterology.

[12]  V. Sepe,et al.  Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. , 2011, Journal of medicinal chemistry.

[13]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[14]  S. Fiorucci,et al.  Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives. , 2006, Journal of medicinal chemistry.

[15]  L. Moore,et al.  Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.

[16]  G. Bifulco,et al.  Solomonsterols A and B from Theonella swinhoei. The first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity. , 2011, Journal of medicinal chemistry.

[17]  H. Nozawa.  Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. , 2005, Biochemical and biophysical research communications.

[18]  G. Bifulco,et al.  Towards new ligands of nuclear receptors. Discovery of malaitasterol A, an unique bis-secosterol from marine sponge Theonella swinhoei. , 2011, Organic & biomolecular chemistry.

[19]  Hans Richter,et al.  Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist. , 2009, Bioorganic & medicinal chemistry letters.

[20]  F. Baldelli,et al.  Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. , 2011, Mini reviews in medicinal chemistry.

[21]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[22]  Ram B. Singh,et al.  Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia , 1994, Cardiovascular Drugs and Therapy.

[23]  Giuseppe Bifulco,et al.  Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor. , 2011, Journal of medicinal chemistry.

[24]  Stefan Westin,et al.  Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). , 2009, Journal of medicinal chemistry.

[25]  Kaixian Chen,et al.  Pyrazolidine-3,5-dione derivatives as potent non-steroidal agonists of farnesoid X receptor: virtual screening, synthesis, and biological evaluation. , 2008, Bioorganic & medicinal chemistry letters.

[26]  T. Willson,et al.  Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. , 2004, Journal of medicinal chemistry.

[27]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[28]  Kazuhide Inoue,et al.  Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation Published, JLR Papers in Press, September 16, 2003. DOI 10.1194/jlr.M300215-JLR200 , 2004, Journal of Lipid Research.

[29]  E. Distrutti,et al.  Targeting farnesoid X receptor for liver and metabolic disorders. , 2007, Trends in molecular medicine.

[30]  X. Hu,et al.  The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. , 2002, Molecular endocrinology.

[31]  S. Nam,et al.  Farnesoid X-activated receptor antagonists from a marine sponge Spongia sp. , 2006, Bioorganic & medicinal chemistry letters.

[32]  F. Baldelli,et al.  Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. , 2010, Progress in lipid research.

[33]  S. Fiorucci,et al.  Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. , 2009, Trends in pharmacological sciences.

[34]  Jaehwan Lee,et al.  Tuberatolides, potent FXR antagonists from the Korean marine tunicate Botryllus tuberatus. , 2011, Journal of natural products.

[35]  M. Makishima,et al.  PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. , 2011, Gastroenterology.

[36]  F. Gonzalez,et al.  Guggulsterone: an old approach to a new problem , 2002, Trends in Endocrinology & Metabolism.

[37]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[38]  A. Mcinnes,et al.  Identification of C-24 alkyl epimers of marine sterols by 13C nuclear magnetic resonance spectroscopy , 1978 .

[39]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[40]  D. Mangelsdorf,et al.  A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR , 2002, Science.